- Home
- ESGRP vs PFE Comparison
ESGRP vs PFE Comparison
Compare ESGRP & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESGRP
- PFE
- Stock Information
- Founded
- ESGRP N/A
- PFE 1849
- Country
- ESGRP Bermuda
- PFE United States
- Employees
- ESGRP 790
- PFE N/A
- Industry
- ESGRP Property-Casualty Insurers
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- ESGRP Finance
- PFE Health Care
- Exchange
- ESGRP Nasdaq
- PFE Nasdaq
- Market Cap
- ESGRP N/A
- PFE 134.2B
- IPO Year
- ESGRP N/A
- PFE N/A
- Fundamental
- Price
- ESGRP $21.18
- PFE $23.37
- Analyst Decision
- ESGRP
- PFE Hold
- Analyst Count
- ESGRP 0
- PFE 14
- Target Price
- ESGRP N/A
- PFE $29.92
- AVG Volume (30 Days)
- ESGRP N/A
- PFE 45.6M
- Earning Date
- ESGRP N/A
- PFE 04-29-2025
- Dividend Yield
- ESGRP N/A
- PFE 7.32%
- EPS Growth
- ESGRP N/A
- PFE N/A
- EPS
- ESGRP N/A
- PFE 1.38
- Revenue
- ESGRP N/A
- PFE $62,464,000,000.00
- Revenue This Year
- ESGRP N/A
- PFE N/A
- Revenue Next Year
- ESGRP N/A
- PFE N/A
- P/E Ratio
- ESGRP N/A
- PFE $17.02
- Revenue Growth
- ESGRP N/A
- PFE 11.65
- 52 Week Low
- ESGRP N/A
- PFE $20.92
- 52 Week High
- ESGRP N/A
- PFE $31.54
- Technical
- Relative Strength Index (RSI)
- ESGRP 59.90
- PFE 51.18
- Support Level
- ESGRP $20.36
- PFE $23.11
- Resistance Level
- ESGRP $21.76
- PFE $23.62
- Average True Range (ATR)
- ESGRP 0.35
- PFE 0.46
- MACD
- ESGRP 0.04
- PFE 0.09
- Stochastic Oscillator
- ESGRP 79.29
- PFE 79.48
About ESGRP Enstar Group Limited Depositary Shares Each Representing 1/1000th of an interest in Preference Shares
Enstar Group Ltd is a (re)insurance group that offers capital release solutions through its network of group companies. It seeks to create value by managing (re)insurance companies and portfolios of (re)insurance and other liability businesses in run-off and striving to generate an attractive risk-adjusted return from its investment portfolio. Its operations are through two reportable segments: Run-off segment and Investments segment.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.